CD4 and cancer: Tumors with high AR expression were reported to be associated with pro-cancer regulatory T cells, and those with low AR expression were associated with anti-cancer immune cells, such as CD4, CD8, gamma delta T cells, and memory B cells in ER-positive breast cancer.